CAC 40
7 992,82 -99,04 (-1,22 %) Euro Stoxx 50
4 933,52 -56,36 (-1,13 %) Dow Jones
38 460,92 -42,77 (-0,11 %) EUR/USD
1,0695 -0,0006 (-0,05 %) Gold future
2 343,10 +4,70 (+0,20 %) Bitcoin EUR
59 362,38 -2 716,38 (-4,38 %)
DaVita Inc. (DVA)
Avant Bourse :
DaVita Inc.
2000 16th Street
Denver, CO 80202
United States
720 631 2100
https://www.davita.com
Secteur(s): Healthcare
Secteur d’activité: Medical Care Facilities
Employés à temps plein: 70 000
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Mr. Javier J. Rodriguez | CEO & Executive Director | 2,98M | 2,49M | 1971 |
| Mr. Joel Ackerman | CFO & Treasurer | 1,19M | S.O. | 1965 |
| Ms. Kathleen Alyce Waters | Chief Legal & Public Affairs Officer | 1,08M | 653,4k | 1968 |
| Mr. James O. Hearty | Chief Compliance Officer | 768,29k | 101,32k | 1969 |
| Mr. Michael David Staffieri | Chief Operating Officer of Kidney Care | 1,65M | S.O. | 1974 |
| Mr. Christopher Michael Berry | Group VP & Chief Accounting Officer | S.O. | S.O. | 1975 |
| Mr. Jim Gustafson | Vice President of Investor Relations | S.O. | S.O. | S.O. |
| Mr. Kenneth Gardner Smith | Chief People Officer | S.O. | S.O. | 1981 |
| Mr. Misha Palecek | Chief Transformation Officer of U.S. Kidney Care Business | S.O. | S.O. | S.O. |
| Dr. Jeffrey Allen Giullian | Chief Medical Officer of Kidney Care | S.O. | S.O. | S.O. |
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Gouvernance d’entreprise
L’ISS Governance QualityScore de DaVita Inc. en date du 1 avril 2024 est 5. Les scores principaux sont Audit : 6; Société : 2; Droits des actionnaires : 3; Compensation : 9.
